Your browser doesn't support javascript.
loading
[Zijin powder in inhibiting H22 mice solid and ascites liver cancer: experimental study].
Wei, Da-wen; Jia, Yu-mei; Li, Zhong-zheng.
Afiliação
  • Wei DW; Henan University of Traditional Chinese Medicine, Zhengzhou 450008, China.
Zhongguo Zhong Yao Za Zhi ; 30(17): 1346-8, 2005 Sep.
Article em Zh | MEDLINE | ID: mdl-16329194
ABSTRACT

OBJECTIVE:

To observe the rate of Zijin powder in inhibiting H22 mice solid and ascites liver cancer and the relation between quatity and effect.

METHOD:

The Kunming mics, transplanted by H22 liver cells, were divided into a model group, a cyclophosphamide group and three groups of Zijin powder in high dose, medium dose, and low dose. Then observation was made on the rate of Cancer.

RESULT:

The inhibiting rates of Zijin powder of three groups (high dose group, medium dose group and low dose group) for H22 mice solid liver cancer were 30.8%, 38.31% and 48.59% respectivily. The inhibiting rates of three groups of Zijin powder (low dose group, medium dose and high dose group) for H22 mice ascites liver cancer were 6.77%, 15.59% and 14.90 % respectivily.

CONCLUSION:

Zijin powder has better effect on H22 mice solid liver cancer, and its effect is greatly increasing with the increased dosage.
Assuntos
Buscar no Google
Base de dados: MEDLINE Medicinas Tradicionais: Medicinas_tradicionales_de_asia / Medicina_china Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas Assunto principal: Medicamentos de Ervas Chinesas / Neoplasias Hepáticas / Fitoterapia / Antineoplásicos Fitogênicos Tipo de estudo: Clinical_trials Idioma: Zh Revista: Zhongguo Zhong Yao Za Zhi Ano de publicação: 2005 Tipo de documento: Article País de afiliação: China
Buscar no Google
Base de dados: MEDLINE Medicinas Tradicionais: Medicinas_tradicionales_de_asia / Medicina_china Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas Assunto principal: Medicamentos de Ervas Chinesas / Neoplasias Hepáticas / Fitoterapia / Antineoplásicos Fitogênicos Tipo de estudo: Clinical_trials Idioma: Zh Revista: Zhongguo Zhong Yao Za Zhi Ano de publicação: 2005 Tipo de documento: Article País de afiliação: China